Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nevanac vs Acular LS: Pain After First Drop
NCT00869219Phase 4Unknown
- Sponsor
- Santa Casa de Santos
- Start
- Mar 2009
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of nepafenac and ketorolac in pain, sponsored by Santa Casa de Santos. Primary endpoint: Pain after instillation. Status: unknown.
02
Drugs
nepafenacketorolac
03
Conditions
pain
Beyond the preview
Go deeper on NCT00869219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00869219.